About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- paracetamol / pseudoephedrine
- Procedure number
- PSUSA/00002307/202306
- Regulatory outcome
- Variation
Documents
Paracetamol / pseudoephedrine : List of nationally authorised medicinal products - PSUSA/00002307/202306
English (EN) (225.17 KB - PDF)
Paracetamol / pseudoephedrine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002307/202306
English (EN) (146.16 KB - PDF)
български (BG) (185.96 KB - PDF)
español (ES) (165.11 KB - PDF)
čeština (CS) (216.91 KB - PDF)
dansk (DA) (151.5 KB - PDF)
Deutsch (DE) (169.81 KB - PDF)
eesti keel (ET) (146.62 KB - PDF)
ελληνικά (EL) (183.64 KB - PDF)
français (FR) (146.15 KB - PDF)
hrvatski (HR) (189.27 KB - PDF)
íslenska (IS) (153.45 KB - PDF)
Gaeilge (GA) (148.77 KB - PDF)
italiano (IT) (157.86 KB - PDF)
latviešu valoda (LV) (208.14 KB - PDF)
lietuvių kalba (LT) (201.36 KB - PDF)
magyar (HU) (224.03 KB - PDF)
Malti (MT) (199.01 KB - PDF)
Nederlands (NL) (166.26 KB - PDF)
norsk (NO) (150.88 KB - PDF)
polski (PL) (209.73 KB - PDF)
português (PT) (151.63 KB - PDF)
română (RO) (179.2 KB - PDF)
slovenčina (SK) (212.48 KB - PDF)
slovenščina (SL) (199.16 KB - PDF)
Suomi (FI) (145.01 KB - PDF)
svenska (SV) (164.13 KB - PDF)